Physician profile
Laura E Dickey
NPI 1881022291
$1,630.84
in general payments reported to CMS, 2019-2025
14 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $280 · 2023: $441 · 2024: $552 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $513.11 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $354.80 | 2024-2025 | Barrigel, Urolift |
| Myovant Sciences INC. | $198.59 | 2022 | |
| Axonics, INC. | $122.73 | 2024 | Bulkamid |
| Ambu INC. | $113.63 | 2023 | |
| Dendreon Pharmaceuticals LLC | $63.18 | 2023 | Provenge |
| Endo Pharmaceuticals INC. | $61.67 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $55.64 | 2023-2024 | Exparel |
| Ferring Pharmaceuticals INC. | $32.21 | 2024 | Adstiladrin |
| Urogen Pharma, INC. | $26.86 | 2024 | |
| Myriad Genetic Laboratories, INC. | $24.00 | 2024 | Prolaris |
| Accord Healthcare, INC. | $22.33 | 2024 | |
| Verity Pharmaceuticals INC. | $22.19 | 2024 | Trelstar |
| Abbvie INC. | $19.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Dickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.